BS69 negatively regulates the canonical NF-κB activation induced by Epstein-Barr virus-derived LMP1

FEBS Letters

Volumn 583, Issue 10, 2009, Pages 1567-1574

  Ikeda, Osamu ^a   Sekine, Yuichi ^a   Mizushima, Akihiro ^a   Oritani, Kenji ^b   Yasui, Teruhito ^c   Fujimuro, Masahiro ^d   Muromoto, Ryuta ^a   Nanbo, Asuka ^a   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

BS69; Epstein Barr virus; Latent membrane protein 1; NF B; TNFR associated death domain protein

Indexed keywords

BINDING PROTEIN; BS69 PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

CARRIER PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTERLEUKIN-6; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 67349205539     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.04.022     Document Type: Article

References (30)

1. Kieff E. Epstein-Barr virus and its replication. In: Field D.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology. vol. 2 3rd ed (1996), Springer, NY 2343-2396
2. Liebowitz D., Wang D., and Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58 (1989) 233-237
3. Li H.P., and Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 10 (2003) 490-504
4. Huen D.S., Henderson S.A., Croom-Carter D., and Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10 (1995) 549-560
5. Brodeur S.R., Cheng G., Baltimore D., and Thorley-Lawson D.A. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272 (1997) 19777-19784
6. Devergne O.E., Hatzivassiliou K.M., Izumi K.M., Kaye K.M., Kleijnen K.F., Kieff E., and Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell Biol. 16 (1996) 7098-7108
7. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., and Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93 (1996) 11085-11090
8. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., and Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80 (1995) 389-399
9. Izumi K.M., and Kieff E. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. USA 94 (1997) 12592-12597
10. Izumi K.M., Cahir-McFarland E.D., Ting A.T., Riley E.A., Seed B., and Kieff E. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Mol. Cell Biol. 19 (1999) 5759-5767
11. Wan J., Zhang W., Wu L., Bai T., Zhang M., Lo K.W., Chui Y.L., Cui Y., Tao Q., Yamamoto M., Akira S., and Wu Z. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Mol. Cell Biol. 26 (2006) 448-456
12. Laherty C.D., Hu H.M., Opipari A.W., Wang F., and Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267 (1992) 24157-24160
13. Luftig M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., Seed B., and Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. USA 101 (2004) 141-146
14. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., and Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274 (1999) 16085-16096
15. Eliopoulos A.G., and Young L.S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16 (1998) 1731-1742
16. Hateboer G., Gennissen A., Ramos Y.F., Kerkhoven R.M., Sonntag-Buck V., Stunnenberg H.G., and Bernards R. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J. 14 (1995) 3159-3169
17. Ansieau S., and Leutz A. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J. Biol. Chem. 277 (2002) 4906-4910
18. Kurozumi K., Nishita M., Yamaguchi K., Fujita T., Ueno N., and Shibuya H. BRAM1, a BMP receptor-associated molecule involved in BMP signaling. Genes Cells 3 (1998) 257-264
19. Ikeda O., Sekine Y., Yasui T., Oritani K., Sugiyma K., Muromoto R., Ohbayashi N., Yoshimura A., and Matsuda T. STAP-2 negatively regulates both canonical and non-canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1. Mol. Cell Biol. 28 (2008) 5027-5042
20. Sekine Y., Yumioka T., Yamamoto R., Muromoto R., Imoto S., Sugiyma K., Oritani K., Shimoda K., Minoguchi M., Akira S., Yoshimura A., and Matsuda T. Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J. Immunol. 176 (2006) 380-389
21. Matsuda T., Yamamoto T., Muraguchi A., and Saatcioglu F. Cross-talk between TGF-eta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276 (2001) 42907-42914
22. Chung P.J., Chang Y.S., Liang C.L., and Meng C.L. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1. J. Biol. Chem. 277 (2002) 39850-39857
23. Phelps W.C., Yee C.L., Münger K., and Howley P.M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53 (1988) 539-547
24. Ladendorff N.E., Wu S., and Lipsick J.S. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb. Oncogene 20 (2001) 125-132
25. Masselink H., Vastenhouw N., and Bernards R. B-myb rescues ras-induced premature senescence, which requires its transactivation domain. Cancer Lett. 171 (2001) 87-101
26. Wei G., Schaffner A.E., Baker K.M., Mansky K.C., and Ostrowski M.C. Ets-2 interacts with co-repressor BS69 to repress target gene expression. Anticancer Res. 23 (2003) 2173-2178
27. Ekblad C.M., Chavali G.B., Basu B.P., Freund S.M., Veprintsev D., Hughes-Davies L., Kouzarides T., Doherty A.J., and Itzhaki L.S. Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69. EMBO Rep. 6 (2005) 675-680
28. Masselink H., and Bernards R. The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR. Oncogene 19 (2000) 1538-1546
29. Velasco G., Grkovic S., and Ansieau S. New insights into BS69 functions. J. Biol. Chem. 281 (2006) 16546-16550
30. Ansieau S., and Leutz A. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J. Biol. Chem. 277 (2002) 4906-4910